Literature DB >> 16885351

A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination.

Kazuyoshi Yanagihara1, Misato Takigahira, Fumitaka Takeshita, Teruo Komatsu, Kazuto Nishio, Fumio Hasegawa, Takahiro Ochiya.   

Abstract

We recently established a mouse model of peritoneal dissemination of human gastric carcinoma, including the formation of ascites, by orthotopic transplantation of cultured gastric carcinoma cells. To clarify the processes of expansion of the tumors in this model, nude mice were sacrificed and autopsied at different points of time after the orthotopic transplantation of the cancer cells for macroscopic and histopathologic examination of the tumors. The cancer cells grew actively in the gastric submucosa and invaded the deeper layers to reach the serosal plane. The tumor cells then underwent exfoliation and became free followed by the formation of metastatic lesions initially in the greater omentum and subsequent colonization and proliferation of the tumors on the peritoneum. Although this model allowed the detection of even minute metastases, it was not satisfactory from the viewpoint of quantitative and objective evaluation. To resolve these problems, we introduced a luciferase gene into this tumor cell line with a high metastasizing potential and carried out in vivo photon counting analysis. This photon counting technique was found to allow objective and quantitative evaluation of the progression of peritoneal dissemination on a real-time basis. This animal metastatic model is useful for monitoring the responses of tumors to anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885351     DOI: 10.1158/0008-5472.CAN-05-3259

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.

Authors:  Fumiko Taguchi; Yasuo Kodera; Yasufumi Katanasaka; Kazuyoshi Yanagihara; Tomohide Tamura; Fumiaki Koizumi
Journal:  Invest New Drugs       Date:  2010-06-08       Impact factor: 3.850

2.  Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer.

Authors:  Erin S Haley; Gough G Au; Brian R Carlton; Richard D Barry; Darren R Shafren
Journal:  J Mol Med (Berl)       Date:  2009-01-13       Impact factor: 4.599

3.  Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts.

Authors:  Masahisa Kudo; Yoshiyuki Yamamoto; Yoshikatsu Koga; Tetsuya Hamaguchi; Tetsuo Akimoto; Masahiro Yasunaga; Yasuhiro Matsumura
Journal:  Mol Clin Oncol       Date:  2016-11-01

4.  Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer.

Authors:  Dai Shimizu; Tomoko Saito; Shuhei Ito; Takaaki Masuda; Junji Kurashige; Yosuke Kuroda; Hidetoshi Eguchi; Yasuhiro Kodera; Koshi Mimori
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

5.  DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.

Authors:  Kensuke Kayamori; Yurie Nagai; Cheng Zhong; Satoshi Kaito; Daisuke Shinoda; Shuhei Koide; Wakako Kuribayashi; Motohiko Oshima; Yaeko Nakajima-Takagi; Masayuki Yamashita; Naoya Mimura; Hans Jiro Becker; Kiyoko Izawa; Satoshi Yamazaki; Satoshi Iwano; Atsushi Miyawaki; Ryoji Ito; Kaoru Tohyama; William Lennox; Josephine Sheedy; Marla Weetall; Emiko Sakaida; Koutaro Yokote; Atsushi Iwama
Journal:  Blood Adv       Date:  2021-01-26

6.  New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice.

Authors:  Akihiro Ito; Yuichi Ito; Shigeru Matsushima; Daisuke Tsuchida; Mai Ogasawara; Junichi Hasegawa; Kazunari Misawa; Eisaku Kondo; Norio Kaneda; Hayao Nakanishi
Journal:  Gastric Cancer       Date:  2013-11-28       Impact factor: 7.370

7.  Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma.

Authors:  Masamitsu Tanaka; Reiko Kamata; Misato Takigahira; Kazuyoshi Yanagihara; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  An experimental brainstem tumor model using in vivo bioluminescence imaging in rat.

Authors:  Akihide Kondo; Stewart Goldman; Elio F Vanin; Simone T Sredni; Veena Rajaram; Marcelo B Soares; Tadanori Tomita
Journal:  Childs Nerv Syst       Date:  2009-01-13       Impact factor: 1.475

9.  Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model.

Authors:  Jun-Eul Hwang; Hyun-Jeong Shim; Young-Kyu Park; Sang-Hee Cho; Woo-Kyun Bae; Dae-Eun Kim; Kyung-Keun Kim; Ik-Joo Chung
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

10.  N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.

Authors:  Hiroki Ureshino; Yuichi Murakami; Kosuke Watari; Hiroto Izumi; Akihiko Kawahara; Masayoshi Kage; Tokuzo Arao; Kazuto Nishio; Kazuyoshi Yanagihara; Hisafumi Kinoshita; Michihiko Kuwano; Mayumi Ono
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.